AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
Financial Statements
- Click here to download Abbvie Inc's Income Statement
- Click here to download Abbvie Inc's Balance Sheet
- Click here to download Abbvie Inc's Statement of Cash Flows
Key Info
- Industry: Pharmaceutical Preparation Manufacturing
- Sector: Manufacturing
- CEO Name: Richard Gonzalez
Key Statistics
- Stock Price: $108.81
- Dividend Yield: 4.8%
- Market Capitalization: $189,883,010,913
- Shares Outstanding: 1,767,175,532
- Number of Employees: 2,020
- Trailing 12-Month EPS: $3.71
- Trailing 12-Month DPS: $5.11
- Payout Ratio: 137.7%
Important Dates
- Next Earnings Date: 2021-10-29
- Next Ex-Dividend Date: 2021-10-14
Price Trends
- Current Stock Price: $108.81
- 52-week high: $120.07
- 52-week low: $75.49
- 200-day moving average: $111.09
- 50-day moving average: $107.45
Performance
- 1-Month Price Return: 0.9%
- 3-Month Price Return: -5.8%
- 6-Month Price Return: 1.2%
- 1-Year Price Return: 33.6%
- 2-Year Price Return: 55.4%
- 5-Year Price Return: 120.1%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast